Fractyl Health Overview
- Year Founded
-
2010

- Status
-
Public
- Employees
-
84

- Stock Symbol
-
GUTS

- Share Price
-
$1.51
- (As of Friday Closing)
Fractyl Health General Information
Description
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Contact Information
Website
www.fractyl.comCorporate Office
- 3 Van de Graaff Drive
- Suite 200
- Burlington, MA 01803
- United States
Corporate Office
- 3 Van de Graaff Drive
- Suite 200
- Burlington, MA 01803
- United States
Fractyl Health Timeline
Fractyl Health Stock Performance
As of 07-Feb-2025, Fractyl Health’s stock price is $1.51. Its current market cap is $72.6M with 48.1M shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.51 | $1.61 | $1.51 - $10.50 | $72.6M | 48.1M | 353K | -$1.58 |
Fractyl Health Financials Summary
As of 30-Sep-2024, Fractyl Health has a trailing 12-month revenue of $97K.
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
---|---|---|---|---|
EV | 80,041 | |||
Revenue | 97 | 120 | 0 | 0 |
EBITDA | (66,295) | (78,065) | (46,798) | (36,617) |
Net Income | (62,904) | (77,091) | (46,453) | (38,735) |
Total Assets | 126,924 | 76,212 | 60,956 | 102,548 |
Total Debt | 62,931 | 86,391 | 19,475 | 17,008 |
Fractyl Health Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Fractyl Health Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
---|
Fractyl Health Comparisons
Industry
Financing
Details
Fractyl Health Competitors (23)
One of Fractyl Health’s 23 competitors is Novo Nordisk, a Corporation company based in Bagsvaerd, Denmark.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Novo Nordisk | Corporation | Bagsvaerd, Denmark | ||||
Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
Carmot Therapeutics | Formerly VC-backed | Berkeley, CA | ||||
Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
Boehringer Ingelheim | Corporation | Ingelheim Am Rhein, Germany |
Fractyl Health Patents
Fractyl Health Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2022419348-A1 | Methods and systems for treating mucosal dysfunction and other medical conditions of a patient | Pending | 22-Dec-2021 | ||
AU-2022414072-A1 | Gene therapies for metabolic disorders | Pending | 15-Dec-2021 | ||
EP-4447986-A1 | Gene therapies for metabolic disorders | Pending | 15-Dec-2021 | ||
AU-2022219999-A1 | System for treating a patient | Pending | 11-Feb-2021 | ||
EP-4291262-A1 | System for treating a patient | Pending | 11-Feb-2021 | A61K9/0019 |
Fractyl Health Signals
Fractyl Health Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Fractyl Health FAQs
-
When was Fractyl Health founded?
Fractyl Health was founded in 2010.
-
Where is Fractyl Health headquartered?
Fractyl Health is headquartered in Burlington, MA.
-
What is the size of Fractyl Health?
Fractyl Health has 84 total employees.
-
What industry is Fractyl Health in?
Fractyl Health’s primary industry is Biotechnology.
-
Is Fractyl Health a private or public company?
Fractyl Health is a Public company.
-
What is Fractyl Health’s stock symbol?
The ticker symbol for Fractyl Health is GUTS.
-
What is the current stock price of Fractyl Health?
As of 07-Feb-2025 the stock price of Fractyl Health is $1.51.
-
What is the current market cap of Fractyl Health?
The current market capitalization of Fractyl Health is $72.6M.
-
What is Fractyl Health’s current revenue?
The trailing twelve month revenue for Fractyl Health is $97K.
-
Who are Fractyl Health’s competitors?
Novo Nordisk, Dicerna Pharmaceuticals, Carmot Therapeutics, Sarepta Therapeutics, and Boehringer Ingelheim are some of the 23 competitors of Fractyl Health.
-
What is Fractyl Health’s annual earnings per share (EPS)?
Fractyl Health’s EPS for 12 months was -$1.58.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »